Related Experiment Video
Updated: Nov 1, 2025

06:54
MR Molecular Imaging of Prostate Cancer with a Small Molecular CLT1 Peptide Targeted Contrast Agent
Published on: September 3, 2013
11.4K
Re: Prostate-specific Membrane Antigen PET-CT in Patients with High-risk Prostate Cancer Before Curative-intent
Vidit Sharma1, R Jeffrey Karnes2
1Department of Urology, Mayo Clinic, Rochester, MN, USA; VA Health Services Research and Development, Department of Urology, UCLA, Los Angeles, CA, USA.
European Urology
|June 27, 2021
Abstract
No abstract available in PubMed .

